Gruenenthal Gmbh

Xention Limited

Gruenethal Gmbh

Grunenthal Gmbh

Jean De Vry

Klaus Schiene

Gregor Bahrenberg

Thomas Christoph

Robert Frank

Derek John Saunders

Jeewoo Lee

Bernd Sundermann

Nils Damann

Bernhard Lesch

Sven Frormann

Yong-Soo Kim

Melanie Reich

Ruth Jostock

Tieno Germann

Sabine Hees

Stefan Oberboersch

Klemens Lustig

Babette-Yvonne Koegel

Stefan Schunk

Michael Engels

Josef Pernerstorfer

Klaus Linz

Elmar Josef Friderichs

Myeong-Seop Kim

Hannelore Stockhausen

Muneto Mogi

Heinrich Meier

Wolfgang Schröder

Michael Przewosny

Klaus Urbahns

Nicole Diedrichs

Wolfgang Schroeder

Masaomi Tajimi

Noriyuki Yamamoto

Hiroshi Fujishima

Takeshi Yura

Yasuhiro Tsukimi

Michael Franz-Martin Engels

Babette-Yvonne Kögel

Christa Kneip

Robert Frank-Foltyn

Achim Hermann

Jewoo Lee

Hyung Chul Ryu

Elke Reissmuller

Hiroaki Yuasa

Jang Gupta

Fumihiko Hayashi

Elke Reissmüller

Substituted phenylureas and phenylamides, processes for their preparation, pharmaceutical compositions containing these compounds, and the use of these compounds for preparing pharmaceutical compositions.

Substituted phenylureas and phenylamides as vanilloid receptor ligands

The invention relates to substituted phenylureas and phenylamides, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions.

Vanilloid receptor ligand compounds corresponding to formula I: a process for producing such compounds, pharmaceutical compositions containing them, and the use of such compounds to treat pain and various other vanilloid receptor mediated conditions.

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

Vanilloid receptor ligand compounds corresponding to formula I: pharmaceutical compositions containing such compounds, a process for producing such compounds, and methods of using such compounds for treating or inhibiting pain and various other disorders or conditions.

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions

Compounds corresponding to formula I: which act as vanilloid receptor ligands, pharmaceutical compositions containing such compounds, a process for the producing such compounds, and the use thereof to treat or inhibit pain and/or various other disorders or conditions.

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions

The present invention relates to novel vanilloid receptor ligands, to a process for the production thereof, to pharmaceutical preparations containing these compounds and to the use of these compounds for the production of pharmaceutical preparations.

Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations

Substituted benzamide compounds corresponding to formula (I) in which R5, R6, R7, R8, a, b, c, d, t, D and X have defined meanings, a process for their preparation, pharmaceutical compositions comprising such compounds, and a method of using such compounds to treat pain and other conditions mediated at least in part via the bradykinin 1 receptor.

Bradykinin 1 receptor modulating compounds

Compounds corresponding to formula I: which act as vanilloid receptor ligands, pharmaceutical compositions containing such compounds, a method for producing the compounds, and the use of such compounds to treat pain and various other conditions.

Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions

Substituted sulfonamide compounds corresponding to the formula I processes for the preparation thereof, pharmaceutical compositions containing these compounds and the use of substituted sulfonamide compounds for the preparation of pharmaceutical compositions for treating pain and other conditions at least partly mediated via the bradykinin 1 receptor.

Substituted sulfonamide compounds

The invention relates to substituted aromatic carboxamide and urea derivatives, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions.

Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands

Substituted sulfonamide compounds corresponding to formula I: processes for the preparation thereof, pharmaceutical compositions containing these compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment and/or inhibition of pain and other conditions at least partly mediated by the bradykinin 1 receptor.

Compounds corresponding to formula I: which act as vanilloid receptor ligands, pharmaceutical composition s containing such compounds, a method for producing the compounds, and the use of such compounds to treat pain and various other conditions.

Growing community of inventors

Stolberg, Germany

Jean De Vry